TIG Advisors LLC’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

TIG Advisors LLC’s Portfolio PSTX Stock Details PSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-685,595	Closed	-$6.58M	–	100
2024 Q4	$6.58M	Buy	+685,595	New	+$3.58M	0.46%	37

Other funds holding PSTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TIG Advisors LLC's PSTX Position: Q1 2025 in Review

TIG Advisors LLC sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 685,595 shares — an estimated $6.58M sold.

TIG Advisors LLC first reported a position in PSTX in Q4 2024 and held it in 1 quarter. The position peaked at $6.58M in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

TIG Advisors LLC reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
TIG Advisors LLC sold 685,595 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $6.58M.
TIG Advisors LLC first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
TIG Advisors LLC's Poseida Therapeutics, Inc. Common Stock position peaked at $6.58M in Q4 2024.
1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on TIG Advisors LLC's 13F filing for Q1 2025, filed 15 May 2025.